Home
>
National Drug Code (NDC)
>
Lustra-AF
Lustra-AF - 51672-1327-3 - (Hydroquinone)
Drug Information of Lustra-AF
| Product NDC: | 51672-1327 |
| Proprietary Name: | Lustra-AF |
| Non Proprietary Name: | Hydroquinone |
| Active Ingredient(s): | 40 mg/g & nbsp; Hydroquinone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lustra-AF
| Product NDC: | 51672-1327 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20050120 |
Package Information of Lustra-AF
| Package NDC: | 51672-1327-3 |
| Package Description: | 1 TUBE in 1 CARTON (51672-1327-3) > 56.8 g in 1 TUBE |
NDC Information of Lustra-AF
| NDC Code | 51672-1327-3 |
| Proprietary Name | Lustra-AF |
| Package Description | 1 TUBE in 1 CARTON (51672-1327-3) > 56.8 g in 1 TUBE |
| Product NDC | 51672-1327 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydroquinone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20050120 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | HYDROQUINONE |
| Strength Number | 40 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA] |
